Brainomix Multicenter Study Demonstrates Potential of Quantitative CT for Earlier Detection of Progressive Pulmonary Fibrosis (PPF)
OXFORD, UK and CHICAGO, Oct 21, 2026 – Brainomix, a leading medtech company specializing in AI-powered imaging tools for lung disease and stroke, today announced the publication of new data…
